Systematic Review And Meta-Analysis Of Briakinumab, A Fully Human Interleukin 12/23 Monoclonal Antibody, For The Treatment Of Moderate To Severe Chronic Plaque Psoriasis
May 1, 2016, 00:00
10.1016/j.jval.2016.03.494
https://www.valueinhealthjournal.com/article/S1098-3015(16)00562-3/fulltext
Title :
Systematic Review And Meta-Analysis Of Briakinumab, A Fully Human Interleukin 12/23 Monoclonal Antibody, For The Treatment Of Moderate To Severe Chronic Plaque Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00562-3&doi=10.1016/j.jval.2016.03.494
First page :
A123
Section Title :
Sensory System Disorders - Clinical Outcomes Studies
Open access? :
No
Section Order :
152